This inventor holds 1 USPTO granted patent. Top assignee: Biomark Technologies, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: The Innovative Contributions of Daniel Sitar
Introduction
Daniel Sitar is a notable inventor based in Richmond, CA. He has made significant contributions to the field of biochemistry, particularly through his innovative patent related to enzyme activity. His work has implications for understanding various pathologic conditions.
Latest Patents
Daniel Sitar holds a patent titled "Method for assaying the activity of spermidine/spermine N1-acetyltransferase." This method involves assaying the activity of the enzyme spermidine/spermine N-acetyltransferase (SSAT) by detecting its acetylated forms. The substrates used in this method include rimantadine and tocainide, which are metabolized by the inducible enzyme SSAT to produce the acetylated metabolites N-acetylrimantadine and N-acetyltocainide. The activity of SSAT may be correlated to various pathologic conditions, making this patent particularly valuable in medical research.
Career Highlights
Daniel Sitar is currently associated with Biomark Technologies, Inc., where he continues to advance his research and development efforts. His work at Biomark Technologies focuses on innovative solutions in the field of biochemistry and enzyme activity.
Collaborations
Daniel has collaborated with several professionals in his field, including Brian Cheng and Rashid Bux. These collaborations have enhanced his research and contributed to the development of his patented methods.
Conclusion
Daniel Sitar's contributions to the field of biochemistry through his innovative patent demonstrate his commitment to advancing scientific knowledge. His work has the potential to impact medical research significantly.